Feed SSMXY
SS

Sysmex Corporation SSMXY OTC · Healthcare · Japan

$13.33 +3.15% +$0.41

Summary

68 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: ¥121.4B against ¥119.5B.
  • Out of every 100 JPY of revenue, 13 JPY is left as free cash.

What to watch

  • You pay 35.9 JPY for 1 JPY of yearly profit, a lot for its sector.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today $13.33

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 35.9 5.2% higher
5-year average P/E 34.1
P/E today 35.9
Medical - Specialties industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 35.9 JPY for 1 JPY of yearly profit. Over the last five years it was 34.1 JPY on average.

Valuation in detail

Is it growing?

Slowly

Revenue (JPY)

Diluted EPS (JPY)

  • Analyst estimate

Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 8.9% a year. For the next fiscal year analysts expect revenue to grow by 3.0%.

Growth in detail

Does it make money?

Very well

Where 100 JPY of revenue goes

Net profit, industry median (Medical - Specialties) 8.1 JPY

Out of every 100 JPY of revenue, 6.4 JPY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.6 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, stretched
Yield
1.72%
Paid out of profit
62%
Raised in a row
1 year

You receive $0.22 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

No analyst has published a price target.

0.0% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy